RWP
CLB icon

RWA Wealth Partners’s Core Laboratories CLB Stock Holding History

RWA Wealth Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-400
Closed -$50K – 316
2018
Q2 		$50K Buy
+400
New +$48.7K 0.01% 413

Other funds holding CLB

WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.3B AUM 39.21% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RWA Wealth Partners's CLB Position: Q3 2018 in Review

RWA Wealth Partners sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 400 shares — an estimated $50K sold.

RWA Wealth Partners first reported a position in CLB in Q2 2018 and held it in 1 quarter. The position peaked at $50K in Q2 2018. 359 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • RWA Wealth Partners reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • RWA Wealth Partners sold 400 Core Laboratories shares in Q3 2018, an estimated $50K.
  • RWA Wealth Partners first reported a position in Core Laboratories in Q2 2018 and held it in 1 quarter.
  • RWA Wealth Partners's Core Laboratories position peaked at $50K in Q2 2018.
  • 359 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on RWA Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.